相关实验视频
Updated: May 20, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.5K
高剂量胰岛素是一种扩散剂,而不是中毒患者的解毒剂!
Katherine Z Isoardi1,2,3, Betty Chan4,5, Angela L Chiew4,5
1Clinical Toxicology Unit, Princess Alexandra Hospital, Brisbane, Australia.
Emergency medicine Australasia : EMA
|March 31, 2025
概括
高剂量胰岛素不是中毒的解药,而是一种内扩散剂. 它最适合二线心脏性休克治疗,而不是孤立的血管性休克,并且需要同时提供诺亚上腺素.
科学领域:
- 毒理学 毒理学 毒理学
- 药理学 药理学是指药理学的学科.
- 关键护理医学 关键护理医学
背景情况:
- 高剂量胰岛素治疗 (HDIT) 越来越多地用于中毒.
- 它经常被误认为是各种药物过量使用的通用解药.
- 这导致了不适当的使用,特别是在由二皮里丁通道阻断剂引起的血管损伤性休克中.
研究的目的:
- 澄清HDIT在中毒管理中的作用.
- 区分HDIT的影响与抗药作用.
- 提供有关在特定中毒情景中适当使用HDIT的指导.
主要方法:
- 对毒理学中HDIT的当前文献的综述.
- 对HDIT的药理性质的分析 (放松剂效果,作用开始).
- 在心脏与血管性休克中HDIT疗效的比较.
主要成果:
- 高强度肌痛症作为一个内扩展剂,而不是直接的解毒剂.
- 它的开始作用 (15-60分钟) 适合心脏性休克的二线治疗.
- 在孤立的血管性休克中,HDIT是无效和潜在的有害的,需要同时提供诺亚上腺素.
结论:
- 在中毒中,HDIT是心脏性休克的二线扩散剂.
- 它不应用于孤立的血管性休克.
- 同时服用诺亚上腺素对于控制胰岛素诱导的血管扩张和低血等不良反应至关重要.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
132
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
132
Prevention of Further Absorption of Poison
777
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
777
Heart Failure Drugs: Inotropic Agents
476
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
476
Antidotes
603
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
603
Anticholinesterase Agents: Poisoning and Treatment
763
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
763
Insulin Formulations: Types and Delivery
145
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
145

